Moderate
Probable
描述
Carbamazepine substantially reduces duloxetine plasma levels through CYP1A2 and CYP3A4 induction, risking loss of antidepressant efficacy.
机制
Carbamazepine induces CYP1A2 and CYP3A4, the primary enzymes responsible for duloxetine oxidative metabolism, significantly increasing its clearance.
临床意义
Duloxetine concentrations may drop well below effective levels; depression or pain relapse is a realistic clinical outcome.
处理措施
Closely monitor clinical response; consider antidepressants less susceptible to enzyme induction (e.g., venlafaxine) if carbamazepine is required.